Want More Insights from FDA Matters? Check Out the Q&A Monday Tab for This Subscriber-First Feature

by Steven Grossman | Oct 3, 2025 | Short Takes and Updates | 0 comments

Permission is granted to reprint or recirculate this column, as long as attribution is made to FDA Matters and the author.

Every Monday, FDA Mtters subscribers receive “Q&A Monday.” They may recirculate, quote from, or reprint it, etc., at their own discretion, which can be particularly useful for media. I do not publicly post the column until the following Monday. You can find past columns on the Q&A Monday tab (here).

If you would like to receive Q&A Monday columns every week “when-issued,” please subscribe on the site or email me at sgrossman@fdamatters.com.

——–

The goal of FDA Matters is to analyze FDA policy and regulatory issues and advocate for a more effective, efficient, and fair FDA.

FDA Matters doesn’t cover the news….we provide analysis of what’s behind the news.

If you would like to subscribe (for free), you can do so on our website (www.fdamatters.com) or by sending a note to sgrossman@fdamatters.com. We recognize that you are busy, so we limit our content to 1-2 columns per week and ensure it is never more than a 3 to 5-minute read.

FDA Matters provides short-form analysis of FDA policy and regulatory issues. We know you are busy, so we publish 1 to 2 columns per week, each a 3-5 minute read.

FDA Matters does not report the news….we provide analysis of what’s behind the news.

FDA Matters advocates for a more effective, efficient, and fair FDA.

FDA Matters has been featured in:

Steven A. Grossman, JD, is the founder and author of FDA Matters. Read more about Steven here.